Почетна › Рак на дојка › Калифорнија › Santa Monica
Клинички испитувања за Рак на дојка во Santa Monica, CA
28 студии за Рак на дојка бараат учесници на локации во и околу Santa Monica (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Се регрутираФаза 3
- Beverly Hills Cancer Center, Beverly Hills · на 6 милји
A Study of PHST001 in Advanced Solid Tumors
Се регрутираФаза 1
- Precision NextGen Oncology & Research Center, Beverly Hills · на 6 милји
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Се регрутираФаза 2
- Beverly Hills Cancer Center, Beverly Hills · на 6 милји
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Се регрутираФаза 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Се регрутира
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
Се регрутираФаза 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · на 6 милји
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Се регрутираФаза 3
- Clinical Trial Site, Beverly Hills · на 6 милји
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Се регрутираФаза 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Се регрутираФаза 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Се регрутираФаза 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Се регрутираФаза 1/2
- Beverly Hills Cancer Center, Beverly Hills · на 6 милји
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Се регрутираФаза 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Се регрутираФаза 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · на 6 милји
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Се регрутираФаза 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Се регрутираФаза 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Се регрутираФаза 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- и уште 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Се регрутираФаза 3
- Tower Cancer Research Foundation, Beverly Hills · на 6 милји
- Cedars-Sinai Cancer - Tarzana, Tarzana · на 11 милји
- Kaiser Permanente-Woodland Hills, Woodland Hills · на 12 милји
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Се регрутираФаза 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · на 6 милји
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
Се регрутираФаза 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · на 11 милји
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Се регрутираФаза 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
Се регрутираФаза 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · на 12 милји
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Се регрутираФаза 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · на 4 милји
- Precision NextGen Oncology & Research Center, Beverly Hills · на 6 милји
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Се регрутираФаза 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Се регрутираФаза 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Се регрутираФаза 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · на 11 милји
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Се регрутираФаза 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Се регрутираНабљудувачка студија
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Испитувања за Рак на дојка во други градови
- New York City, NY136 студии
- Houston, TX126 студии
- Boston, MA112 студии
- Nashville, TN81 студија
- Los Angeles, CA73 студии
- Edison, NJ68 студии
- St. Louis, MO64 студии
- Queens, NY64 студии
- Durham, NC64 студии
- Chicago, IL59 студии
- Philadelphia, PA56 студии
- Dallas, TX55 студии
Други студии во Santa Monica
- Рак на бели дробови со не-мали клетки45 студии
- Колоректален карцином23 студии
- Рак (сите типови)22 студии
- Метастатски карцином19 студии
- Рак на бели дробови15 студии
- Карцином на јајниците15 студии
- Рак на простата15 студии
- Сквамозноклеточен карцином на глава и врат13 студии
- Срцева слабост11 студии
- Рак на ендометриумот10 студии
- Рак на стомакот9 студии
- Карцином на панкреасот9 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.